Ann: Change of Director's Interest Notice - MM, page-8

The market is ascribing nearly zero chance of this getting off the ground.
But say there’s a 10% chance it does...

Normal ivf cycle is 5k ish. If the cartridge can increase fertility rates by even 5% or decrease fetal anomalies by anything statistically significant then even in Australia if only 50% of cycles used the cartridges you could imagine up to 20000 cartridges per year. They could sell them for 500 bucks at a gross margin in excess of 75% I believe (mass produced the cartridge wouldn’t cost more than 100 I think but clearly guessing)
400*20000 gross profit of 8mil just for aus.
Aiming for European ce next year. Extrapolate that out to Europe.

Anyway long and the short is this has an enormous tam ‘if’ it works, and ‘if’ the patents are well thought out.